Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0015436031
Mon, 19.04.2021
CureVac
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
- Rolling submission to accelerate time to marketing authorization of CVnCoV in Switzerland
- Review process started with submission of first CVnCoV data package
TÜBINGEN, Germany/ BOSTON, USA - April 19, 2021 - The CureVac S [ … ]
Thu, 15.04.2021
CureVac
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
- COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission
- Pivotal Phase 2b/3 in Europe and Latin America fully recruited [ … ]
Fri, 09.04.2021
CureVac
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
TÜBINGEN, Germany/ BOSTON, USA - April 9, 2021 - CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results and bus [ … ]